Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858

Watchlist Manager
Shandong Buchang Pharmaceuticals Co Ltd Logo
Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
Watchlist
Price: 16.3 CNY 0.06% Market Closed
Market Cap: 17.2B CNY

Shandong Buchang Pharmaceuticals Co Ltd
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Shandong Buchang Pharmaceuticals Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Shandong Buchang Pharmaceuticals Co Ltd
SSE:603858
Revenue
ÂĄ11B
CAGR 3-Years
-11%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ13.2B
CAGR 3-Years
10%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ9.8B
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
19%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ31B
CAGR 3-Years
13%
CAGR 5-Years
4%
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ40.8B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
7%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ5.8B
CAGR 3-Years
94%
CAGR 5-Years
37%
CAGR 10-Years
N/A
No Stocks Found

Shandong Buchang Pharmaceuticals Co Ltd
Glance View

Market Cap
17.2B CNY
Industry
Pharmaceuticals

Shandong Buchang Pharmaceuticals Co Ltd, a stalwart in China's pharmaceutical industry, was founded with a traditional focus but a modern vision. The company thrives on its deep expertise in developing and manufacturing traditional Chinese medicine (TCM) products, capitalizing on the rich tapestry of Eastern medicinal practices. Its extensive portfolio spans cardiovascular, cerebrovascular, and neurological disorders, areas highly pertinent to China’s aging population. By seamlessly integrating modern scientific techniques with age-old herbal wisdom, Buchang positions itself uniquely in a market that appreciates both tradition and innovation. This dual focus allows the company to tap into the growing demand for health solutions that marry efficacy with cultural familiarity. Financially, Buchang Pharmaceuticals' revenue is primarily fueled by its established healthcare products, which are marketed extensively across China’s vast healthcare network. The company shrewdly invests in building dedicated sales channels, leveraging a combination of direct engagement with healthcare professionals and strategic partnerships with medical institutions. Their emphasis on R&D ensures a steady pipeline of products, aiming to break into new therapeutic areas and expand its market presence. Buchang’s strategy to blend traditional remedies with modern delivery forms not only bolsters its domestic sales but also paves the way for potential international expansion, as global interest in holistic and alternative health solutions continues to grow. This sophisticated operational model underscores Buchang's ability to adapt and prosper amid shifting healthcare paradigms.

Intrinsic Value
17.03 CNY
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Shandong Buchang Pharmaceuticals Co Ltd's Revenue?
Revenue
11B CNY

Based on the financial report for Sep 30, 2025, Shandong Buchang Pharmaceuticals Co Ltd's Revenue amounts to 11B CNY.

What is Shandong Buchang Pharmaceuticals Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
-6%

Over the last year, the Revenue growth was -7%. The average annual Revenue growth rates for Shandong Buchang Pharmaceuticals Co Ltd have been -11% over the past three years , -6% over the past five years .

Back to Top